Anti-DTNBP1 antibodies are used in the immunodetection of the protein dystrobrevin binding protein 1. In humans, the canonical protein has a reported length of 351 amino acid residues and a mass of 39.5 kDa. Its subcellular localization is in the cell membrane, nucleus, cytoplasmic vesicles, ER, and cytoplasm. It is notably expressed in the brain, in neurons and in neuropil. A member of the Dysbindin protein family, DTNBP1 is a known component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes. Synonyms for this target antigen include BLOC-1 subunit 8, Hermansky-Pudlak syndrome 7 protein, biogenesis of lysosomal organelles complex-1, subunit 8, biogenesis of lysosome-related organelles complex 1 subunit 8, dysbindin-1, and dysbindin. DTNBP1 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. A number of DTNBP1 antibodies have been mentioned in research publications and have associated citations. Immunohistochemistry is a widely used application for these antibodies. Western Blot and Immunofluorescence are also common applications.